For one terrible night in March 2010, in a field clinic outside Port-au-Prince, Haiti, I watched a child die of typhoid fever. She had arrived earlier in the day from a tent city, one of many wretched ...

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj. ® Multi-dose is manufactured ...

Seattle, United States & Seoul, Republic of Korea—PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi ...

A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...

Baltimore, MD — October 8, 2025 — Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical ...

Typhoid fever, an illness that has been controlled in developed countries since the early 20th century, is evolving to be antibiotic-resistant. Research published in 2022 shows that typhoid is ...

A medic from Mater Hospital administers the typhoid vaccine to a child during the wellness clinic in Buruburu, Nairobi, on July 13, 2025. The campaign for mass vaccination for typhoid and measles ends ...